ZTS NYSE
Zoetis Inc.
1W: -2.3%
1M: +9.5%
3M: +0.3%
YTD: -37.6%
1Y: -46.2%
3Y: -52.0%
5Y: -60.2%
$78.23
-2.74 (-3.38%)
Weekly Expected Move ±3.6%
$75
$78
$81
$84
$87
Credit Risk of going bust: lower than 57% of companies Debt: 22.2% of company value Bonds: $301.2M held by 308 funds, 68 bp over Treasuries → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.76 (down 98%), Zoetis Inc. would be worth roughly what it owes.
Total debt $9.24B against a stock market value of $32.33B.
Distance to default 5.81 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.52B (short-term plus half of long-term), stock volatility 40.4%; Altman Z 4.73. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.76 (down 98%), Zoetis Inc. would be worth roughly what it owes.
Total debt $9.24B against a stock market value of $32.33B.
Distance to default 5.81 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.52B (short-term plus half of long-term), stock volatility 40.4%; Altman Z 4.73. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
2 bullish
0 neutral
0 bearish
Articles (24h)
2
Hourly Sentiment (24h)
0.36
Bullish
3 bullish
1 neutral
1 bearish
Articles (7d)
5
Daily Sentiment (7 Days)
Articles (100)
3 Absurdly Cheap Dividend Stocks to Buy for Under $100 Right Now
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
From worst to first? These battered S&P 500 stocks bounce back
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note
ZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?
8,293 Zoetis Inc. $ZTS Shares Sold by Banque Pictet & Cie SA
Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focus
Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know
A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now
Zoetis declares $0.53 dividend
S&P 500 hits a record; These $20B stocks still need 200% to break even
Burry flags six stocks as likely tax-loss sale candidates
40,294 Zoetis Inc. $ZTS Shares Purchased by Rockland Trust Co.
Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why
483,862 Zoetis Inc. $ZTS Shares Sold by Envestnet Asset Management Inc.
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note
S&P 500 nears record level, but breadth shows signs of stress
Healthcare stocks with the strongest dividend growth grades
Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note
10 large and mega-cap U.S. healthcare stocks with the weakest momentum grades
Corient Private Wealth LP Has $35.07 Million Holdings in Zoetis Inc. $ZTS
Zoetis Inc. $ZTS Shares Sold by Capital Analysts LLC
Michael Burry pulls back on risk, sheds December 2026 Nvidia and Palantir puts amid portfolio-wide cuts
HB Wealth Management LLC Boosts Holdings in Zoetis Inc. $ZTS
B. Metzler seel. Sohn & Co. AG Trims Stock Holdings in Zoetis Inc. $ZTS
Ancora Advisors LLC Has $2.64 Million Position in Zoetis Inc. $ZTS
Highest and lowest quant-rated healthcare stocks above $10B cap after earnings season
Michael Burry’s portfolio: How his bullish and bearish bets fared In August
Blackhill Capital Inc. Cuts Stock Position in Zoetis Inc. $ZTS
3 High-Yielding Dividend Stocks That Have Doubled Their Payouts in 5 Years
BlackRock Inc. Grows Position in Zoetis Inc. $ZTS
Zoetis (ZTS) Q2 2026 Earnings Call Transcript
Burry adds to AI shorts, says ‘Nebius is what the top of a boom looks like’
Assenagon Asset Management S.A. Lowers Position in Zoetis Inc. $ZTS
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Pfizer in focus
Earnings Scorecard: 95% of healthcare firms deliver EPS wins this week
ZTS Q2 Earnings Call Flags Deeper Companion Animal Pressure
Zoetis Q2 Earnings Beat Estimates, Revenues Miss, 2026 View Cut
Here's What Key Metrics Tell Us About Zoetis (ZTS) Q2 Earnings
Zoetis (ZTS) Surpasses Q2 Earnings Estimates
USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates
Gear Up for Zoetis (ZTS) Q2 Earnings: Wall Street Estimates for Key Metrics
ZTS Set to Report Q2 Earnings: Here's What Investors Should Expect
Zoetis (ZTS) Reports Next Week: Wall Street Expects Earnings Growth
Zoetis (ZTS) Beats Stock Market Upswing: What Investors Need to Know
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
AIA Group Ltd Sells 28,502 Shares of Zoetis Inc. $ZTS
Key deals this week: Eli Lilly, PayPal, Uber and more
Zoetis, Neogen deal draws antitrust concerns in Australia
Seeking Alpha’s Quant Spotlight: Highest and lowest rated healthcare stocks ahead of Q2
These large-cap stocks head into Q2 earnings with Sell ratings
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
Zoetis to acquire VitalRADS, a provider of veterinary imaging services
ZTS Wins European Commission Approval for New Poultry Disease Vaccine
Notable healthcare headlines for the week: Abbott, AstraZeneca, and Eli Lilly in focus
Michael Burry says he shorted Micron Technology
S&P 500 caps strongest quarter since 2020: Here's what drove the rally
Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focus
Zoetis (ZTS) Suffers a Larger Drop Than the General Market: Key Insights
Strength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength?
The Best Stocks to Invest $1,000 in Right Now
Zoetis (ZTS) Surpasses Market Returns: Some Facts Worth Knowing
NYSE: ZTS: Kessler Topaz Meltzer & Check, LLP Announces the Filing of a Securities Fraud Class Action Lawsuit Against Zoetis Inc.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
Moderna hires commercial chief ahead of multiple product launches
ZTS Shareholder Alert: July 27, 2026 Lead Plaintiff Deadline in Zoetis Inc. Securities Class Action - Contact Levi & Korsinsky
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
Zoetis (ZTS) Stock Dips While Market Gains: Key Facts
Bragar Eagel & Squire, P.C. Reminds Zoetis, Inc. Investors that a Class Action Lawsuit Has Been Filed Against Zoetis and Encourages Investors to Contact the Firm Before the July 27th Deadline
PAHC Stock: What's Driving Phibro's Animal Health Growth
Is PAHC Undervalued at 10x Earnings vs Peers?
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
ZTS INVESTOR ALERT: Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit - RGRD Law
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Zoetis Inc. of Class Action Lawsuit and Upcoming Deadlines – ZTS
Deadline Alert: Zoetis Inc. (ZTS) Shareholders Who Lost Money Urged to Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
ZTS Deadline Alert: The Gross Law Firm Reminds Zoetis Inc. (ZTS) Investors of Securities Class Action Deadline on July 27, 2026
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Zoetis Inc. (ZTS)
ZOETIS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Zoetis, Inc. and Encourages Investors to Contact the Firm
ZTS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
ZTS Investors Have Opportunity to Lead Zoetis Inc. Securities Fraud Lawsuit with the Schall Law Firm
ROSEN, A HIGHLY REGARDED LAW FIRM, Encourages Zoetis Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ZTS
ZTS Shareholder Alert: Zoetis Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
ZTS Class Action Reminder - Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Zoetis Inc. Class Acton Lawsuit
ZTS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Zoetis Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
DEADLINE ALERT for AVAV, CALX, and ZTS: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
ZOETIS INC. (ZTS) INVESTOR ALERT Investors With Large Losses in Zoetis Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights
Bronstein, Gewirtz & Grossman LLC Urges Zoetis Inc. Investors to Act: Class Action Filed Alleging Investor Harm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zoetis Inc. - ZTS
Notable healthcare headlines for the week: UnitedHealth, Boston Scientific, and Eli Lilly in focus
Notable healthcare headlines for the week: UnitedHealth, Bristol Myers Squibb, and Hims & Hers in focus
Catalyst Watch: Nvidia blockbuster, PMIs, GTA 6 watch, and the Apple Store turns 25
Major Purchase Alert: MICHAEL MCCALLISTER Invests $233K In Zoetis Stock
Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus
Most healthcare companies report higher Y/Y EPS in strong earnings week
Company News for May 8, 2026
Zoetis (ZTS) Q1 2026 Earnings Transcript
Zoetis projects 2%-5% 2026 revenue growth as U.S. companion animal demand softens
Why Zoetis Shares Plummeted Today
US Pet Care Demand Is Weak - Zoetis Cuts Outlook